|
2025-05-19 |
2025-05-16 |
S
Sale
|
PISKEL KYLE
Chief Financial Officer
Officer
|
1,929
-0.7%
8.89
USD 17,149
|
1,929
-0.7%
|
8.89
|
USD 17,149
|
|
|
2025-05-05 |
2025-05-01 |
PS
Planned sale
|
ROBINS HARLAN S
Chief Scientific Officer
Officer
|
68,412
-5.1%
7.35
USD 502,828
|
68,412
-5.1%
|
7.35
|
USD 502,828
|
|
|
2025-03-26 |
2025-03-24 |
PS
Planned sale
|
ROBINS HARLAN S
Chief Scientific Officer
Officer
|
1,698
-0.1%
9.00
USD 15,282
|
1,698
-0.1%
|
9.00
|
USD 15,282
|
|
|
2025-03-17 |
2025-03-13 |
S
Sale
|
GRIFFIN MICHELLE RENEE
Non-Executive Director
|
36,291
-70.2%
7.19
USD 260,932
|
36,291
-70.2%
|
7.19
|
USD 260,932
|
|
|
2025-03-12 |
2025-03-12 |
S
Sale
|
HERSHBERG ROBERT
Non-Executive Director
|
53,000
-43.2%
7.59
USD 402,270
|
53,000
-43.2%
|
7.59
|
USD 402,270
|
|
|
2025-03-12 |
2025-03-10 |
S
Sale
|
NEUPERT PETER M
Non-Executive Director
|
10,000
-4.3%
7.05
USD 70,500
|
10,000
-4.3%
|
7.05
|
USD 70,500
|
|
|
2025-03-06 |
2025-03-06 |
PS
Planned sale
|
GRIFFIN MICHELLE RENEE
Non-Executive Director
|
15,664
-23.3%
7.94
USD 124,372
|
15,664
-23.3%
|
7.94
|
USD 124,372
|
|
|
2025-03-06 |
2025-03-06 |
S
Sale
|
ROBINS CHAD M
CEO and Chairman
Executive Director
|
102,218
-3.3%
7.64
USD 780,946
|
102,218
-3.3%
|
7.64
|
USD 780,946
|
|
|
2025-03-06 |
2025-03-05 |
S
Sale
|
LO FRANCIS
Chief People Officer
Officer
|
13,790
-4.0%
6.99
USD 96,392
|
13,790
-4.0%
|
6.99
|
USD 96,392
|
|
|
2025-03-06 |
2025-03-05 |
S
Sale
|
LO FRANCIS
Chief People Officer
Officer
|
7,085
-2.0%
6.98
USD 49,453
|
7,085
-2.0%
|
6.98
|
USD 49,453
|
|
|
2025-03-06 |
2025-03-05 |
S
Sale
|
BOBULSKY SUSAN
Chief Commercial Officer, MRD
Officer
|
26,023
-7.0%
6.98
USD 181,641
|
26,023
-7.0%
|
6.98
|
USD 181,641
|
|
|
2025-03-06 |
2025-03-05 |
S
Sale
|
PISKEL KYLE
Chief Financial Officer
Officer
|
6,964
-2.5%
6.99
USD 48,678
|
6,964
-2.5%
|
6.99
|
USD 48,678
|
|
|
2025-03-06 |
2025-03-05 |
S
Sale
|
PISKEL KYLE
Chief Financial Officer
Officer
|
253
-0.1%
6.98
USD 1,766
|
253
-0.1%
|
6.98
|
USD 1,766
|
|
|
2025-03-06 |
2025-03-05 |
S
Sale
|
PISKEL KYLE
Chief Financial Officer
Officer
|
3,103
-1.1%
6.97
USD 21,628
|
3,103
-1.1%
|
6.97
|
USD 21,628
|
|
|
2025-03-06 |
2025-03-05 |
S
Sale
|
BENZENO SHARON
Chief Commercial Ofc Imm Med
Officer
|
3,065
-0.8%
6.99
USD 21,424
|
3,065
-0.8%
|
6.99
|
USD 21,424
|
|
|
2025-03-06 |
2025-03-05 |
S
Sale
|
BENZENO SHARON
Chief Commercial Ofc Imm Med
Officer
|
41,600
-9.5%
6.98
USD 290,368
|
41,600
-9.5%
|
6.98
|
USD 290,368
|
|
|
2025-03-06 |
2025-03-05 |
S
Sale
|
RUBINSTEIN JULIE
President and COO
Officer
|
19,461
-3.2%
6.99
USD 136,032
|
19,461
-3.2%
|
6.99
|
USD 136,032
|
|
|
2025-03-06 |
2025-03-05 |
S
Sale
|
RUBINSTEIN JULIE
President and COO
Officer
|
40,044
-6.2%
6.98
USD 279,507
|
40,044
-6.2%
|
6.98
|
USD 279,507
|
|
|
2025-03-06 |
2025-03-05 |
S
Sale
|
ROBINS HARLAN S
Chief Scientific Officer
Officer
|
56,053
-4.2%
6.99
USD 391,810
|
56,053
-4.2%
|
6.99
|
USD 391,810
|
|
|
2025-03-06 |
2025-03-05 |
S
Sale
|
ROBINS HARLAN S
Chief Scientific Officer
Officer
|
40,603
-3.0%
6.98
USD 283,409
|
40,603
-3.0%
|
6.98
|
USD 283,409
|
|
